## ASML: ASML Holding N.V. - New York Re - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -1.4% below STRENGTH zone (3.0-6.0%); PEG 2.12 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1015.61)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Hereâ€™s What Boosted ASML Holding N.V. (ASML) in Q3**
- Source: Insider Monkey | 20251216T071900 | Bullish | Relevance: 100%
- Magellan Global Fund's Q3 2025 investor letter highlighted ASML Holding N.V. (NASDAQ: ASML) as a significant contributor to its performance. The semiconductor company benefited from positive sentiment in the sector due to OpenAI's partnerships and Nvidia's strategic investment in Intel. Despite ASML's strong performance, the fund suggests that some AI stocks may offer higher returns within a shorter timeframe.

**2. Geneos Wealth Management Inc. Increases Stock Holdings in ASML Holding N.V. $ASML**
- Source: MarketBeat | 20251215T090904 | Bullish | Relevance: 100%
- Geneos Wealth Management Inc. significantly increased its stake in ASML Holding N.V. by 242.6% in the second quarter, acquiring an additional 4,798 shares to own a total of 6,776 shares valued at approximately $5.43 million. ASML reported strong quarterly earnings, beating analyst estimates, although revenue slightly missed expectations. The company also recently raised its quarterly dividend to $1.857 per share and has a "Moderate Buy" consensus rating from analysts with an average price target of $1,171.83.

**3. Marex Group plc Purchases Shares of 2,417 ASML Holding N.V. $ASML**
- Source: MarketBeat | 20251214T120924 | Bullish | Relevance: 100%
- Marex Group plc initiated a new position in ASML Holding N.V. (NASDAQ:ASML) during the second quarter, acquiring 2,417 shares valued at approximately $1.94 million. ASML has a "Moderate Buy" consensus rating from analysts with a target price of $1,171.83, and its financial performance shows solid earnings and revenue, alongside a recently increased quarterly dividend. The company, a key player in semiconductor equipment, has seen significant institutional interest and positive analyst upgrades.

**4. 5,389 Shares in ASML Holding N.V. $ASML Acquired by B. Riley Wealth Advisors Inc.**
- Source: MarketBeat | 20251214T090925 | Somewhat-Bullish | Relevance: 100%
- B. Riley Wealth Advisors Inc. has acquired 5,389 shares of ASML Holding N.V., valued at approximately $4.32 million, as part of increased institutional investment in the semiconductor company. ASML notably exceeded EPS forecasts but slightly missed revenue expectations, and the company has raised its quarterly dividend to $1.857, translating to an annualized yield of about 0.7%. Analyst sentiment towards ASML remains largely positive, with an average "Moderate Buy" rating and a price target of $1,171.83.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | B of A Securiti | $1331 | $1092 | +22% |
| 2025-12-01 | JP Morgan | $1275 | $1175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | B of A Securiti | main | Buy |
| 2025-12-01 | JP Morgan | main | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 8.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 1.5% (+170.0%)
- Fisher Asset Managem: 1.1% (+2.5%)
- Capital World Invest: 1.1% (-4.1%)
- Capital Internationa: 1.0% (+17.3%)
- State Farm Mutual Au: 0.7% (0.0%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.4% 5d) with bearish MACD, trend may be turning.
2. Premium valuation (P/E 42x, PEG 2.1x) vulnerable to multiple compression.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.12 elevated, pricing in significant growth expectations. Forward P/E 41.5x stretched relative to 5% growth. Quality metrics strong (ROE 54%, ROA 16%, margin 29%). Analyst sentiment positive (2 raises, avg +15%). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $417.7B |
| Beta | 1.35 |
| 52W Range | $578.51 - $1141.72 |
| Short Interest | 0.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.12 |
| Forward P/E | 41.5 |
| Current P/E | 43.5 |
| YoY Growth | 4.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.9% to -1.4% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.5pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.30), momentum weakening. RSI neutral at 52. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.45% (CS: 22) | Neutral |
| RSI_14 | 51.9 | Neutral |
| MACD Histogram | -2.30 | Bearish |
| vs SMA20 | 1.008x | Above |
| vs SMA50 | 1.033x | Above |
| vs SMA200 | 1.303x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1076.05
- **Stop Loss:** $1015.61 (5.6% risk)
- **Target:** $1136.49 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 16
- **Position Value:** $17,216.80
- **Portfolio %:** 17.22%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-01-28 (Est: $7.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.37 | $5.49 | +2.1% |
| 2025Q2 | $5.25 | $5.90 | +12.4% |
| 2025Q1 | $5.79 | $6.00 | +3.7% |
| 2024Q4 | $6.73 | $6.84 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*